97 related articles for article (PubMed ID: 1961277)
1. FDA approves Epoetin Alfa use for AZT patients.
Nephrol News Issues; 1991 Apr; 5(4):11. PubMed ID: 1961277
[No Abstract] [Full Text] [Related]
2. Epoetin alpha approved for anemic AIDS patients.
J Am Osteopath Assoc; 1991 Jun; 91(6):538. PubMed ID: 1874651
[No Abstract] [Full Text] [Related]
3. [The use of erythropoietin in HIV myelodysplasias. Preliminary study].
Fruttaldo L; Gatti G; Deambrogio V; Mongiò F; Schettino G; Cavagnolo G
Minerva Med; 1993 Mar; 84(3):103-5. PubMed ID: 8492960
[TBL] [Abstract][Full Text] [Related]
4. FDA notifications. FDA approves generic AZT.
AIDS Alert; 2007 Jul; 22(7):79. PubMed ID: 17763553
[No Abstract] [Full Text] [Related]
5. Epoietin alfa (EPO) for anemia.
Hanna L
BETA; 1998 Jul; ():40, 42. PubMed ID: 11365562
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of recombinant human erythropoietin versus transfusions in the treatment of zidovudine-related anemia in HIV-infected children.
Allen UD; Kirby MA; Goeree R
Pediatr AIDS HIV Infect; 1997 Feb; 8(1):4-11. PubMed ID: 11361510
[TBL] [Abstract][Full Text] [Related]
7. [Erythropoietin treatment of anemia associated with human immunodeficiency virus infection].
Moreno García M
Med Clin (Barc); 1997 Feb; 108(7):266-71. PubMed ID: 9121196
[No Abstract] [Full Text] [Related]
8. FDA notifications. FDA issues public health advisory about ESAs.
AIDS Alert; 2007 May; 22(5):57-8. PubMed ID: 17580370
[No Abstract] [Full Text] [Related]
9. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
[No Abstract] [Full Text] [Related]
10. Experience with epoetin alfa and acquired immunodeficiency syndrome anemia.
Henry DH
Semin Oncol; 1998 Jun; 25(3 Suppl 7):64-8. PubMed ID: 9671334
[TBL] [Abstract][Full Text] [Related]
11. FDA approves first new class of HIV drugs. Food and Drug Administration.
AIDS Alert; 1996 Aug; 11(8):89. PubMed ID: 11363655
[TBL] [Abstract][Full Text] [Related]
12. FDA approves Eprex for anemia related to AIDS.
Nurse Pract; 1989 Sep; 14(9):6. PubMed ID: 2779868
[No Abstract] [Full Text] [Related]
13. Use of zidovudine in HIV infection.
Am Fam Physician; 1991 May; 43(5):1852. PubMed ID: 2021110
[No Abstract] [Full Text] [Related]
14. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
[TBL] [Abstract][Full Text] [Related]
15. A new approach to managing chemotherapy-related anemia: nursing implications of epoetin alfa.
Rieger PT; Haeuber D
Oncol Nurs Forum; 1995; 22(1):71-81. PubMed ID: 7708526
[TBL] [Abstract][Full Text] [Related]
16. Two drugs in one pill.
Vazquez E
Posit Aware; 1997; 8(6):19. PubMed ID: 11364854
[TBL] [Abstract][Full Text] [Related]
17. Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection.
Hester EK; Peacock JE
AIDS; 1998 Mar; 12(4):439-40. PubMed ID: 9520175
[No Abstract] [Full Text] [Related]
18. Clinical uses of hematopoietic growth hormones in HIV-related illnesses.
Mitsuyasu RT
AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940
[No Abstract] [Full Text] [Related]
19. FDA notifications. Watch out for counterfeit Procrit, 2 lot numbers.
AIDS Alert; 2002 Aug; 17(8):101-2. PubMed ID: 12647690
[No Abstract] [Full Text] [Related]
20. FDA notifications. FDA approves half-strength Kaletra.
AIDS Alert; 2008 Jan; 23(1):10. PubMed ID: 18572474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
